Cited by 914Stress Responses and CortisolNeuropeptides and Animal PhysiologyNeuroendocrine regulation and behavior

The DOI matches its Crossref record; 643 of the 656 references it cites were found in a registry or an index.

Neuroendocrine pharmacology of stress

Carrasco, Gonzalo A, Van de Kar, Louis D·2003·European Journal of Pharmacology

Open this paper in CoChat — free account

Abstract

Exposure to hostile conditions initiates responses organized to enhance the probability of survival. These coordinated responses, known as stress responses, are composed of alterations in behavior, autonomic function and the secretion of multiple hormones. The activation of the renin-angiotensin system and the hypothalamic-pituitary-adrenocortical axis plays a pivotal role in the stress response. Neuroendocrine components activated by stressors include the increased secretion of epinephrine and norepinephrine from the sympathetic nervous system and adrenal medulla, the release of corticotropin-releasing factor (CRF) and vasopressin from parvicellular neurons into the portal circulation, and seconds later, the secretion of pituitary adrenocorticotropin (ACTH), leading to secretion of glucocorticoids by the adrenal gland. Corticotropin-releasing factor coordinates the endocrine, autonomic, behavioral and immune responses to stress and also acts as a neurotransmitter or neuromodulator in the amygdala, dorsal raphe nucleus, hippocampus and locus coeruleus, to integrate brain multi-system responses to stress. This review discussed the role of classical mediators of the stress response, such as corticotropin-releasing factor, vasopressin, serotonin (5-hydroxytryptamine or 5-HT) and catecholamines. Also discussed are the roles of other neuropeptides/neuromodulators involved in the stress response that have previously received little attention, such as substance P, vasoactive intestinal polypeptide, neuropeptide Y and cholecystokinin. Anxiolytic drugs of the benzodiazepine class and other drugs that affect catecholamine, GABA(A), histamine and serotonin receptors have been used to attenuate the neuroendocrine response to stressors. The neuroendocrine information for these drugs is still incomplete; however, they are a new class of potential antidepressant and anxiolytic drugs that offer new therapeutic approaches to treating anxiety disorders. The studies described in this review suggest that multiple brain mechanisms are responsible for the regulation of each hormone and that not all hormones are regulated by the same neural circuits. In particular, the renin-angiotensin system seems to be regulated by different brain mechanisms than the hypothalamic-pituitary-adrenal system. This could be an important survival mechanism to ensure that dysfunction of one neurotransmitter system will not endanger the appropriate secretion of hormones during exposure to adverse conditions. The measurement of several hormones to examine the mechanisms underlying the stress response and the effects of drugs and lesions on these responses can provide insight into the nature and location of brain circuits and neurotransmitter receptors involved in anxiety and stress.

Integrity signals

Registry

Crossref · 10.1016/s0014-2999(03)01285-8

Cites

643 of 643 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Items 201–400 of 643

Chronic fluoxetine induces a gradual desensitization of 5-HT1A receptors: reductions in hypothalamic and midbrain Gi and G(o) proteins and in neuroendocrine responses to a 5-HT1A agonist.
Li, Q., Muma, N. A., & de Kar, L. D. V. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21219-8 · Cited by 165
Facilitation of Feedback Inhibition Through Blockade of Glucocorticoid Receptors in the Hippocampus
van Haarst, A. D., Oitzl, M. S., & de Kloet, E. R. (1997) · Neurochemical Research · doi:10.1023/a:1022010904600 · Cited by 163
Interconnections between the Neuroendocrine Hypothalamus and the Central Autonomic System
Palkovits, M. (1999) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1999.0186 · Cited by 160
Novel Ligand Specificity of Pituitary Vasopressin Receptors in the Rat
Antoni, F. A. (2008) · Neuroendocrinology · doi:10.1159/000123976 · Cited by 159
Branching projections of catecholaminergic brainstem neurons to the paraventricular hypothalamic nucleus and the central nucleus of the amygdala in the rat.
Petrov, T., Krukoff, T. L., & Jhamandas, J. H. (1993) · Brain Research · doi:10.1016/0006-8993(93)90858-k · Cited by 159
Escapable and inescapable stress differentially and selectively alter extracellular levels of 5-HT in the ventral hippocampus and dorsal periaqueductal gray of the rat
Amat, J., Matus-Amat, P., Watkins, L. R., & Maier, S. F. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00368-0 · Cited by 158
Behavioral and endocrine adaptation, and up-regulation of NPY expression in rat amygdala following repeated restraint stress
Thorsell, A., Carlsson, K., Ekman, R., & Heilig, M. A. (1999) · Neuroreport · doi:10.1097/00001756-199909290-00024 · Cited by 157
Distribution of neuropeptide Y-like immunoreactivity in the rat central nervous system—I. Radioimmunoassay and chromatographic characterisation
de Quidt, M. E., & Emson, P. C. (1986) · Neuroscience · doi:10.1016/0306-4522(86)90056-4 · Cited by 157
Corticosterone, brain mineralocorticoid receptors (MRS) and the activity of the hypothalamic-pituitary-adrenal (hpa) axis: The Lewis rat as an example of increased central MR capacity and a hyporesponsive HPA axis
Oitzl, M. S., van Haarst, A. D., Sutanto, W., & de Kloet, E. R. (1995) · Psychoneuroendocrinology · doi:10.1016/0306-4530(95)00003-7 · Cited by 155
Multiple feedback regulatory loops upon rat hypothalamic corticotropin-releasing hormone secretion. Potential clinical implications.
Calogero, A. E., Gallucci, W. T., Gold, P. W., & Chrousos, G. P. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113677 · Cited by 154
Gender differences in the efficacy of fluoxetine and maprotiline in depressed patients: a double-blind trial of antidepressants with serotonergic or norepinephrinergic reuptake inhibition profile
Martényi, F., Dossenbach, M. R. K., Mraz, K., & Metcalfe, S. (2001) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(01)00089-x · Cited by 154
Hypophysiotropic neurons of the paraventricular nucleus respond in spatially, temporally, and phenotypically differentiated manners to acute vs. repeated restraint stress: Rapid publication
Viau, V., & Sawchenko, P. E. (2002) · The Journal of Comparative Neurology · doi:10.1002/cne.10178 · Cited by 153
Receptor Binding, Behavioral, and Electrophysiological Profiles of Nonpeptide Corticotropin-Releasing Factor Subtype 1 Receptor Antagonists CRA1000 and CRA1001
Okuyama, S., Chaki, S., Kawashima, N., Suzuki, Y., Ogawa, S., Nakazato, A., Kumagai, T., Okubo, T., & Tomisawa, K. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38220-5 · Cited by 152
A Desensitization of Hypothalamic 5-HT1A Receptors by Repeated Injections of Paroxetine: Reduction in the Levels of Gi and Go Proteins and Neuroendocrine Responses, but Not in the Density of 5-HT1AReceptors
Li, Q., Muma, N. A., Battaglia, G., & de Kar, L. D. V. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36965-4 · Cited by 149
Neuroendocrinology in Physiology and Medicine
(2000) · Humana Press eBooks · doi:10.1007/978-1-59259-707-9 · Cited by 148
Corticosteroid responses to limbic stimulation in man: Localization of stimulus sites
Rubin, R. T., Mandell, A. J., & Crandall, P. H. (1966) · Science · doi:10.1126/science.153.3737.767 · Cited by 148
Endogenous Opioid Peptides Modulate the Effect of Corticotropin-Releasing Factor on Gonadotropin Release in the Primate*
Gindoff, P. R., & Ferin, M. (1987) · Endocrinology · doi:10.1210/endo-121-3-837 · Cited by 147
Pharmacological Evidence Supporting a Role for Central Corticotropin-Releasing Factor2 Receptors in Behavioral, but not Endocrine, Response to Environmental Stress
Pelleymounter, M. A., Joppa, M. A., LING, N. C., & Foster, A. C. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.302.1.145 · Cited by 147
Molecular Pharmacology of Human Vasopressin Receptors
Thibonnier, M., Conarty, D. M., Preston, J. A., Wilkins, P. L., Berti‐Mattera, L. N., & Mattera, R. (1998) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4871-3_34 · Cited by 145
Ibotenic Acid Lesions in the Bed Nucleus of the Stria terminalis Attenuate Conditioned Stress-Induced Increases in Prolactin, ACTH and Corticosterone
Gray, T. S., Piechowski, R. A., Yracheta, J., Rittenhouse, P. A., Bethea, C. L., & de Kar, L. D. V. (2008) · Neuroendocrinology · doi:10.1159/000126400 · Cited by 145
A non peptidic corticotropin releasing factor receptor antagonist attenuates fever and exhibits anxiolytic-like activity
Lundkvist, J., Chai, Z., Teheranian, R., Hasanvan, H., Bartfai, T., Jenck, F., Widmer, U., & Moreau, J.-L. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00337-8 · Cited by 145
Cerebrospinal Fluid Immunoreactive Cortieotropin-Releasing Hormone and Adrenocorticotropin Secretion in Cushing's Disease and Major Depression: Potential Clinical Implications
Kling, M. A., Roy, A., Doran, R. J., Calabrese, J. R., Rubinow, D. R., DAVID, H. J., May, C., Post, R. M., Chrousos, G. P., & Gold, P. W. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-2-260 · Cited by 145
Characterization of Three Corticotropin-Releasing Factor Receptors in Catfish: A Novel Third Receptor Is Predominantly Expressed in Pituitary and Urophysis*†*The nucleotide sequences reported in this paper have been submitted to the GenBank database with accession numbers cfCRF-R1, AF229359; cfCRF-R2, AF229360; and cfCRF-R3, AF229361.†This work was supported by NIDDK Grant 45020–04A1 from the NIH.
Arai, M., Assil, I. Q., & Abou‐Samra, A. (2001) · Endocrinology · doi:10.1210/endo.142.1.7879 · Cited by 144
Changes in monoamine oxidase and monoamines with human development and aging
Robinson, D. S. (1975) · Springer eBooks · doi:10.1007/978-1-4684-2631-1_23 · Cited by 142
Immunocytochemical localization of nuclear estrogen receptors and progestin receptors within the rat dorsal raphe nucleus
Alves, S. E., Weiland, N. G., Hayashi, S., & McEwen, B. S. (1998) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19980216)391:3 · Cited by 140
CCK in Anxiety and Cognitive Processes
Daugé, V., & Léna, I. (1998) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(98)00011-6 · Cited by 139
The Human V3 Pituitary Vasopressin Receptor: Ligand Binding Profile and Density-Dependent Signaling Pathways
Thibonnier, M., Preston, J. A., Dulin, N. O., Wilkins, P. L., Berti‐Mattera, L. N., & Mattera, R. (1997) · Endocrinology · doi:10.1210/endo.138.10.5432 · Cited by 138
Role of endogenous substance P in stress-induced activation of mesocortical dopamine neurones
Bannon, M. J., Elliott, P. J., Alpert, J. E., Goedert, M., Iversen, S. D., & Iversen, L. L. (1983) · Nature · doi:10.1038/306791a0 · Cited by 136
Role of the hypothalamic paraventricular nucleus in 5-HT1A, 5-HT2A and 5-HT2C receptor-mediated oxytocin, prolactin and ACTH/corticosterone responses
Bagdy, G. (1995) · Behavioural Brain Research · doi:10.1016/0166-4328(96)00112-x · Cited by 133
Effects of conditioned fear stress on serotonin neurotransmission and freezing behavior in rats
Hashimoto, S., Inoue, T., & Koyama, T. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00441-0 · Cited by 133
Temporal Changes in Plasma Adrenocorticotropin Concentration after Repeated Neurotropic Stress in Male and Female Rats
MEVEL, L. J. C., ABITBOL, S., BERAUD, G., & MANIEY, J. (1979) · Endocrinology · doi:10.1210/endo-105-3-812 · Cited by 133
Effect of microinjection of muscimol into the dorsomedial or paraventricular hypothalamic nucleus on air stress-induced neuroendocrine and cardiovascular changes in rats
Stotz‐Potter, E. H., Morin, S. M., & DiMicco, J. A. (1996) · Brain Research · doi:10.1016/s0006-8993(96)01011-6 · Cited by 132
Antagonism of CRF2 receptors produces anxiolytic behavior in animal models of anxiety
Takahashi, L. K., Ho, S. P., Livanov, V., Graciani, N., & Arneric, S. P. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02405-2 · Cited by 132
Corticotropin‐releasing factor: an antireproductive hormone of the testis
Dufau, M. L., Tinajero, J. C., & Fabbri, A. (1993) · The FASEB Journal · doi:10.1096/fasebj.7.2.8382638 · Cited by 129
The Role of Adrenal Nerves in the Regulation of Adrenocortical Functionsa
HOLZWARTH, M. A., CUNNINGHAM, L. A., & KLEITMAN, N. (1987) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1987.tb24980.x · Cited by 129
Vasoactive intestinal peptide-containing neurons in the paraventricular nucleus may participate in regulating prolactin secretion.
Mezey, É., & Kiss, J. Z. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.1.245 · Cited by 129
A single social defeat experience selectively stimulates the release of oxytocin, but not vasopressin, within the septal brain area of male rats
Ebner, K., Wotjak, C. T., Landgraf, R., & Engelmann, M. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02464-1 · Cited by 129
Adrenergic mechanisms in the control of corticotrophin secretion
Al‐Damluji, S. (1988) · Journal of Endocrinology · doi:10.1677/joe.0.1190005 · Cited by 127
Immunochistochemical Analysis of the Localization of Neuropeptides in the Adrenal Gland
Kondo, H. (1985) · Archivum histologicum japonicum · doi:10.1679/aohc.48.453 · Cited by 127
Blockade of CCK-sub(B) but not CCK-sub(A) receptors before and after the stress of predator exposure prevents lasting increases in anxiety-like behavior: Implications for anxiety associated with posttraumatic stress disorder.
Adamec, R. E., Shallow, T., & Budgell, J. (1997) · Behavioral Neuroscience · doi:10.1037//0735-7044.111.2.435 · Cited by 127
BIBP 3226, the first selective neuropeptide Y1 receptor antagonist: A review of its pharmacological properties
Doods, H. N., Wieland, H., Engel, W. W., Eberlein, W. G., Willim, K., Entzeroth, M., Wienen, W., & Rudolf, K. D. (1996) · Regulatory Peptides · doi:10.1016/0167-0115(96)00074-2 · Cited by 127
Human corticotropin-releasing hormone in depression—correlation with thyrotropin secretion following thyrotropin-releasing hormone
Holsboer, F., Gerken, A., von Bardeleben, U., Grimm, W., Beyer, H., Müller, O. A., & Stalla, G. K. (1986) · Biological Psychiatry · doi:10.1016/0006-3223(86)90121-6 · Cited by 126
Regulation of the Hypothalamic-Pituitary-Adrenocortical System in Mice Deficient for CRH Receptors 1 and 2
Preil, J., Müller, M. B., Gesing, A., Reul, J. M. H. M., Sillaber, I., van Gaalen, M. M., Landgrebe, J., Holsboer, F., Stenzel‐Poore, M. P., & Wurst, W. (2001) · Endocrinology · doi:10.1210/endo.142.11.8507 · Cited by 126
Distribution of corticotropin-releasing factor in rat brain.
Palkovits, M., Brownstein, M. J., & Vale, W. W. (1985) · PubMed · Cited by 126
Corticotropin-Releasing Factor Disrupts Sensory Responses of Brain Noradrenergic Neurons
Valentino, R. J., & Foote, S. L. (2008) · Neuroendocrinology · doi:10.1159/000124700 · Cited by 125
5-HT1A receptor responsivity in anxiety disorders and depression
Lesch, K. (1991) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(91)90001-h · Cited by 125
Expression of corticotropin releasing hormone receptors type I and type II mRNA in suicide victims and controls
Hiroi, N., Wong, M. L., Licinio, J., Park, C., Young, M., Gold, P. W., Chrousos, G. P., & Bornstein, S. R. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000908 · Cited by 124
Neurobiology of cholecystokinin.
Moran, T. H., & Schwartz, G. J. (1994) · PubMed · Cited by 123
Fluoxetine efficacy in menopausal women with and without estrogen replacement
Amsterdam, J. D., García‐España, F., Fawcett, J., Quitkin, F. M., Reimherr, F. W., Rosenbaum, J. F., & Beasley, C. M. (1999) · Journal of Affective Disorders · doi:10.1016/s0165-0327(98)00203-1 · Cited by 123
Evidence for regional heterogeneity in corticotropin‐releasing factor interactions in the dorsal raphe nucleus
Valentino, R. J., Liouterman, L., & Bockstaele, E. J. V. (2001) · The Journal of Comparative Neurology · doi:10.1002/cne.1043 · Cited by 122
Stress-Induced Secretion of Adrenocorticotropin in Rats Is Inhibited by Administration of Antisera to Ovine Corticotropin-Releasing Factor and Vasopressin*
Linton, E. A., Tilders, F. J. H., Hodgkinson, S. C., BERKENBOSCH, F., Vermes, I., & Lowry, P. J. (1985) · Endocrinology · doi:10.1210/endo-116-3-966 · Cited by 122
Vasoactive Intestinal Polypeptide Is Synthesized in Anterior Pituitary Tissue*
Arnaout, M. A., Garthwaite, T. L., Martinson, D. R., & Hagen, T. C. (1986) · Endocrinology · doi:10.1210/endo-119-5-2052 · Cited by 122
Characterization and visualization of cholecystokinin receptors in rat brain using [3H]pentagastrin
Gaudreau, P., Quirion, R., St-Pierre, S. A., & Pert, C. B. (1983) · Peptides · doi:10.1016/0196-9781(83)90032-3 · Cited by 121
Activation of the Locus Ceruleus Brain Noradrenergic System during Stress: Circuitry, Consequences, and Regulation
Valentino, R. J., Curtis, A. L., Page, M. E., Pavcovich, L. A., & Florin-Lechner, S. M. (1997) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60863-7 · Cited by 120
Serotonin reuptake inhibitors reduce conditioned fear stress-induced freezing behavior in rats
Hashimoto, S., Inoue, T., & Koyama, T. (1996) · Psychopharmacology · doi:10.1007/bf02246175 · Cited by 120
Differential Effects of Serotonin (5-HT 1A and 5-HT 2 ) Agonists and Antagonists on Renin and Corticosterone Secretion
Lorens, S. A., & de Kar, L. D. V. (2008) · Neuroendocrinology · doi:10.1159/000124754 · Cited by 120
Effect of reserpine and colchicine on neuropeptide mRNA levels in the rat hypothalamic paraventricular nucleus
Ceccatelli, S., Cortés, R., & Hökfelt, T. G. M. (1991) · Molecular Brain Research · doi:10.1016/0169-328x(91)90130-p · Cited by 119
Chemically defined collateral projections from the pons to the central nucleus of the amygdala and hypothalamic paraventricular nucleus in the rat
Petrov, T., Krukoff, T. L., & Jhamandas, J. H. (1994) · Cell and Tissue Research · doi:10.1007/bf00327776 · Cited by 118
Rapid Internalization and Recycling of the Human Neuropeptide Y Y1 Receptor
Gicquiaux, H., Lecat, S., Gaire, M., Dieterlen, A., Mély, Y., Takeda, K., Bucher, B., & Galzi, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107224200 · Cited by 117
Regulation of corticotropin-releasing factor neuronal systems and hypothalamic-pituitary-adrenal axis activity by stress and chronic antidepressant treatment
Stout, S. C., Owens, M. J., & Nemeroff, C. B. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.3.1085 · Cited by 117
Anxiety-like behavior in mice lacking the angiotensin II type-2 receptor
Okuyama, S., Sakagawa, T., Chaki, S., Imagawa, Y., Ichiki, T., & Inagami, T. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01098-7 · Cited by 116
Relationships between plasma corticosteroids and benzodiazepines in stress.
Fur, G. L., Guilloux, F., Mitrani, N., Mizoule, J., & Uzan, A. (1979) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)31832-x · Cited by 115
Corticotropin-releasing hormone receptor (type I) antisense targeting reduces anxiety
Skutella, T., Probst, J. C., Renner, U., Holsboer, F., & Behl, C. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00682-9 · Cited by 114
Brain Neuropeptide Υ (NPY) in Stress and Alcohol Dependence
Heilig, M. A., & Thorsell, A. (2002) · Reviews in the Neurosciences · doi:10.1515/revneuro.2002.13.1.85 · Cited by 114
Reduction of substance P after chronic antidepressants treatment in the striatum, substantia nigra and amygdala of the rat
Shirayama, Y., Mitsushio, H., Takashima, M., Ichikawa, H., & Takahashi, K. (1996) · Brain Research · doi:10.1016/s0006-8993(96)00812-8 · Cited by 113
Cholecystokinin in anxiety
van Megen, H. J. G. M., Westenberg, H. G. M., den Boer, J. A., & Kahn, R. (1996) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(96)00038-7 · Cited by 113
Signal transduction pathways of the human V1-vascular, V2-renal, V3-pituitary vasopressin and oxytocin receptors
Thibonnier, M., Berti‐Mattera, L. N., Dulin, N. O., Conarty, D. M., & Mattera, R. (1999) · Progress in brain research · doi:10.1016/s0079-6123(08)61568-x · Cited by 112
The involvement of noradrenergic ascending pathways in the stress-induced activation of ACTH and corticosterone secretions is dependent on the nature of stressors
Gaillet, S., Lachuer, J., Malaval, F., ASSENMACHER, I., & SZAFARCZYK, A. (1991) · Experimental Brain Research · doi:10.1007/bf00228518 · Cited by 112
In vivo measurement of hypothalamic serotonin release by intracerebral microdialysis: Significant enhancement by immobilization stress in rats
Shimizu, N., Take, S., Hori, T., & Oomura, Y. (1992) · Brain Research Bulletin · doi:10.1016/0361-9230(92)90252-s · Cited by 112
Prevention of stress-induced weight loss by third ventricle CRF receptor antagonist
Smagin, G. N., Howell, L. A., Redmann, S. M., Ryan, D. H., & Harris, R. B. S. (1999) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1999.276.5.r1461 · Cited by 111
Blockade of CCKB but not CCKA receptors before and after the stress of predator exposure prevents lasting increases in anxiety-like behavior: Implications for anxiety associated with posttraumatic stress disorder.
Adamec, R. E., Shallow, T., & Budgell, J. (1997) · Behavioral Neuroscience · doi:10.1037/0735-7044.111.2.435 · Cited by 111
Localization of glial cell line-derived neurotrophic factor receptor alpha and c-ret mRNA in rat central nervous system
Glazner, G. W., Mu, X., & Springer, J. E. (1998) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19980202)391:1 · Cited by 110
Corticotropin-releasing factor administered into the locus coeruleus, but not the parabrachial nucleus, stimulates norepinephrine release in the prefrontal cortex.
Smagin, G., Świergiel, A., & Dunn, A. (1995) · Brain Research Bulletin · doi:10.1016/0361-9230(94)00166-x · Cited by 110
Dorsal raphe stimulation differentially modulates dopaminergic neurons in the ventral tegmental area and substantia nigra
Gervais, J., & Rouillard, C. (2000) · Synapse · doi:10.1002/(sici)1098-2396(20000315)35:4 · Cited by 109
Anxiolytic Action of a Neurokinin1 Receptor Antagonist in the Social Interaction Test
File, S. E. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)90002-2 · Cited by 108
THE PHYSIOLOGY OF CHOLECYSTOKININ IN BRAIN AND GUT
Dockray, G. J. (1982) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a071769 · Cited by 108
Region-Specific Neuropeptide Y Overflows at Rest and During Sympathetic Activation in Humans
Morris, M. J., Cox, H. S., Lambert, G. W., Kaye, D. M., Jennings, G., Meredith, I. T., & Esler, M. (1997) · Hypertension · doi:10.1161/01.hyp.29.1.137 · Cited by 107
Effects of microinjections of the neuropeptide substance P in the dorsal periaqueductal gray on the behaviour of rats in the plus-maze test
Aguiar, M. S., & Brandão, M. L. (1996) · Physiology & Behavior · doi:10.1016/0031-9384(96)00156-4 · Cited by 107
Selective Activation of the Hypothalamic Vasopressinergic System in Mice Deficient for the Corticotropin-Releasing Hormone Receptor 1 Is Dependent on Glucocorticoids
Müller, M. B., Landgraf, R., Preil, J., Sillaber, I., Kresse, A. E., Keck, M. E., Zimmermann, S., Holsboer, F., & Wurst, W. (2000) · Endocrinology · doi:10.1210/endo.141.11.7767 · Cited by 107
Regulation of corticotropin-releasing factor type 1 (CRF1) receptor messenger ribonucleic acid in the paraventricular nucleus of rat hypothalamus by exogenous CRF
Mansi, J. A., Rivest, S., & Drolet, G. (1996) · Endocrinology · doi:10.1210/endo.137.11.8895325 · Cited by 107
Vasopressin and oxytocin mRNA regulation in the rat assessed by hybridization with synthetic oligonucleotides.
Majzoub, J. A., Rich, A., BOOM, J. H. V., & Habener, J. F. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43818-x · Cited by 105
CRF activates autonomic nervous system and reduces natural killer cytotoxicity
Irwin, M. R., Hauger, R. L., Brown, M., & Britton, K. T. (1988) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1988.255.5.r744 · Cited by 105
Estrogen desensitizes 5-HT1A receptors and reduces levels of Gz, Gi1 and Gi3 proteins in the hypothalamus
Raap, D. K., DonCarlos, L. L., García, F., Muma, N. A., Wolf, W. A., Battaglia, G., & de Kar, L. D. V. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00264-6 · Cited by 105
Immobilization stress elevates gene expression for catecholamine biosynthetic enzymes and some neuropeptides in rat sympathetic ganglia: effects of adrenocorticotropin and glucocorticoids
Nankova, B. B., Květňanský, R., Hiremagalur, B., Sabban, B. A., Rusnák, M., & Sabban, E. L. (1996) · Endocrinology · doi:10.1210/endo.137.12.8940389 · Cited by 104
Mesencephalic cuneiform nucleus and its ascending and descending projections serve stress-related cardiovascular responses in the rat
Korte, S. M., Jaarsma, D., Luiten, P. G. M., & Bohus, B. (1992) · Journal of the Autonomic Nervous System · doi:10.1016/0165-1838(92)90137-6 · Cited by 104
Ovarian steroid effects on serotonin 1A, 2A and 2C receptor mRNA in macaque hypothalamus
Gundlah, C., Pecins-Thompson, M., Schutzer, W. E., & Bethea, C. L. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00295-2 · Cited by 104
Strain differences in hypothalamic-pituitary-adrenal activity and stress ulcer
Redei, E., Paré, W. P., Aird, F., & Kluczynski, J. (1994) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1994.266.2.r353 · Cited by 102
Effects of physiological manipulations on locus coeruleus neuronal activity in freely moving cats. I. Thermoregulatory challenge
Morilak, D. A., Fornal, C. A., & Jacobs, B. L. (1987) · Brain Research · doi:10.1016/0006-8993(87)90535-x · Cited by 102
Previous stress alters corticotropin-releasing factor neurotransmission in the locus coeruleus
Curtis, A. L., Pavcovich, L. A., Grigoriadis, D. E., & Valentino, R. J. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00496-r · Cited by 102
Corticotropin-releasing factor up-regulates its own receptor mRNA in the paraventricular nucleus of the hypothalamus
Imaki, T., Naruse, M., Harada, S., Chikada, N., Imaki, J., Onodera, H., Demura, H., & Vale, W. W. (1996) · Molecular Brain Research · doi:10.1016/0169-328x(96)00011-3 · Cited by 101
Chronic Administration of the Selective Corticotropin-Releasing Factor 1 Receptor Antagonist CP-154,526: Behavioral, Endocrine and Neurochemical Effects in the Rat
Arborelius, L., Skelton, K. H., Thrivikraman, K. V., Plotsky, P. M., Schulz, D. W., & Owens, M. J. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39110-4 · Cited by 101
Suppressed neuropeptide Y (NPY) mRNA in rat amygdala following restraint stress
Thorsell, A., Svensson, P., Wiklund, L., Sommer, W. H., Ekman, R., & Heilig, M. A. (1998) · Regulatory Peptides · doi:10.1016/s0167-0115(98)00075-5 · Cited by 100
Chronic electroconvulsive shock treatment elicits up-regulation of CRF and AVP mRNA in select populations of neuroendocrine neurons
Herman, J. P., Schäfer, M. K.-H., Sladek, C. D., Day, R. W., Young, E. A., Akil, H., & Watson, S. J. (1989) · Brain Research · doi:10.1016/0006-8993(89)90641-0 · Cited by 100
Frontal 5-HT 2A receptors studied in depressive patients during chronic treatment by selective serotonin reuptake inhibitors
Massou, J. M., Trichard, C., Attar-Levy, D., Féline, A., Corruble, E., Beaufils, B., & Martinot, J. (1997) · Psychopharmacology · doi:10.1007/s002130050377 · Cited by 99
Evidence that the effects of arginine-8-vasopressin (AVP) on pituitary corticotropin (ACTH) release are mediated by a novel type of receptor
Antoni, F. A., Holmes, M. C., Makara, G. B., Kárteszi, M., & László, F. A. (1984) · Peptides · doi:10.1016/0196-9781(84)90080-9 · Cited by 98
Pituitary-Adrenal Function in the Absence of Vasopressin
McCann, S. M., Antunes‐Rodrigues, J., Nallar, R., & Valtin, H. (1966) · Endocrinology · doi:10.1210/endo-79-6-1058 · Cited by 97
New molecular forms of cholecystokinin. Microsequence analysis of forms previously characterized by chromatographic methods.
Reeve, J. R., Eysselein, V. E., Walsh, J. H., Ben-Avram, C. M., & Shively, J. E. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)66578-0 · Cited by 96
Buspirone augmentation of selective serotonin reuptake inhibitors (SSRIs) in social phobia
Ameringen, M. V. (1996) · Journal of Affective Disorders · doi:10.1016/0165-0327(96)00030-4 · Cited by 95
Antisera to Vasoactive Intestinal Polypeptide Inhibit Basal Prolactin Release from Dispersed Anterior Pituitary Cells
Hagen, T. C., Arnaout, M. A., Scherzer, W. J., Martinson, D. R., & Garthwaite, T. L. (2008) · Neuroendocrinology · doi:10.1159/000124594 · Cited by 95
Subtype-selective cholecystokinin receptor antagonists block cholecystokinin modulation of dopamine-mediated behaviors in the rat mesolimbic pathway
Crawley, J. (1992) · Journal of Neuroscience · doi:10.1523/jneurosci.12-09-03380.1992 · Cited by 95
Multiple neuropeptide Y receptors are involved in cardiovascular regulation. Peripheral and central mechanisms
Grundemar, L., & Håkanson, R. (1993) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(93)90151-m · Cited by 94
Stress-induced anorexia in rats mediated by serotonergic mechanisms in the hypothalamus
Shimizu, N., Oomura, Y., & Kai, Y. (1989) · Physiology & Behavior · doi:10.1016/0031-9384(89)90045-0 · Cited by 94
Opposing regulation of the locus coeruleus by corticotropin-releasing factor and opioids
Bockstaele, E. V., & Valentino, R. J. (2001) · Psychopharmacology · doi:10.1007/s002130000673 · Cited by 94
The Cholecystokinin Hypothesis of Anxiety and Panic Disordera
Bradwejn, J., & Koszycki, D. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb44075.x · Cited by 93
Stress-induced activation of prefrontal cortex dopamine turnover: blockade by lesions of the amygdala
Davis, M., Hithcock, J. M., Bowers, M. B., Berridge, C. W., Melia, K. R., & Roth, R. H. (1994) · Brain Research · doi:10.1016/0006-8993(94)91972-0 · Cited by 93
Selective Blockade of Neurokinin-2 Receptors Produces Antidepressant-Like Effects Associated with Reduced Corticotropin-Releasing Factor Function
Steinberg, R., Alonso, R., Griebel, G., Bert, L., Jung, M., Oury-Donat, F., Poncelet, M., Gueudet, C., Desvignes, C., Fur, G. L., et al. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29250-8 · Cited by 93
Central tachykinins: mediators of defence reaction and stress reactions
Čulman, J., & Unger, T. A. (1995) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y95-122 · Cited by 92
Effects of Chronic Oestrogen Replacement on Stress‐Induced Activation of Hypothalamic‐Pituitary‐Adrenal Axis Control Pathways
Dayas, C. V., Xu, Y., Buller, K. M., & Day, T. A. (2000) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2000.00527.x · Cited by 91
Long-Term Regulation of Locus Ceruleus Sensitivity to Corticotropin-Releasing Factor by Swim Stress
Curtis, A. L., Pavcovich, L. A., & Valentino, R. J. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38261-8 · Cited by 91
Effect of Vasoactive Intestinal Peptide (VIP) on the Release of Adenohypophyseal Hormones from Purified Cells Obtained by Unit Gravity Sedimentation
Rostène, W. H., Benoist, L., Besson, J., Béraud, G., Bluet‐Pajot, M., Kordon, C., Rosselin, G., & Duval, J. (2008) · Neuroendocrinology · doi:10.1159/000123089 · Cited by 91
Short‐term restraint stress and s.c. saline injection alter the tissue levels of substance P and cholecystokinin in the peri‐aqueductal grey and limbic regions of rat brain
ROSÉN, A., Brodin, K., Eneroth, P. H. E., & Brodin, E. (1992) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1992.tb09428.x · Cited by 91
Regulation of pituitary corticotropin releasing hormone receptors
Aguilera, G., Rabadan‐Diehl, C., & Nikodémová, M. (2001) · Peptides · doi:10.1016/s0196-9781(01)00390-4 · Cited by 91
Long-term fluoxetine produces behavioral anxiolytic effects without inhibiting neuroendocrine responses to conditioned stress in rats
Zhang, Y., Raap, D. K., García, F., Serres, F., Ma, Q., Battaglia, G., & de Kar, L. D. V. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02289-1 · Cited by 91
Evidence for Functional Release of Endogenous Opioids in the Locus Ceruleus during Stress Termination
Curtis, A. L., Bello, N. T., & Valentino, R. J. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-13-j0001.2001 · Cited by 91
Ultrastructural Evidence for Endogenous Vasoactive Intestinal Peptide-Like Immunoreactivity in the Pituitary Gland
Morel, G., Besson, J., Rosselin, G., & Dubois, P. M. (2008) · Neuroendocrinology · doi:10.1159/000123282 · Cited by 90
Cerebrospinal fluid corticotropin-releasing factor concentrations in patients with anxiety disorders and normal comparison subjects
Fossey, M. D., Lydiard, R. B., Ballenger, J. C., Laraia, M. T., Bissette, G., & Nemeroff, C. B. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00197-2 · Cited by 90
Neuropeptides: Regulators of Physiological Processes
Iversen, L. L. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01429-0 · Cited by 90
5-HT1A Receptor Function in Normal Subjects on Clinical Doses of Fluoxetine Blunted Temperature and Hormone Responses to Ipsapirone Challenge
Lerer, B. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00106-7 · Cited by 89
Co‐release of neuropeptide Y and catecholamines upon adrenal activation in the cat
Lundberg, J. M., Fried, G., Pernow, J., & THEODORSSON‐NORHEIM, E. (1986) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1986.tb07810.x · Cited by 89
Systemic naloxone administration potentiates locus coeruleus noradrenergic neuronal activity under stressful but not non-stressful conditions.
Abercrombie, E., & Jacobs, B. (1988) · Brain Research · doi:10.1016/0006-8993(88)91415-1 · Cited by 89
Cholecystokinins in the central nervous system and neurohypophysis
Vanderhaeghen, J. J., Lotstra, F., Vierendeels, G., Gilles, C., Deschepper, C. F., & Verbanck, P. (1981) · Peptides · doi:10.1016/0196-9781(81)90016-4 · Cited by 89
The comparative pharmacology of new antidepressants.
Leonard, B. E. (1993) · PubMed · Cited by 88
The role of VIP/PACAP receptor subtypes in spinal somatosensory processing in rats with an experimental peripheral mononeuropathy
Dickinson, T., Mitchell, R., Robberecht, P., & Fleetwood-Walker, S. M. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(98)00171-3 · Cited by 87
Molecular biology of vasopressin receptors
LOLAIT, S. J., O'CARROLL, A., & BROWNSTEIN, M. J. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb44688.x · Cited by 87
Increased serotonin release in mice frontal cortex and hippocampus induced by acute physiological stressors
Fujino, K., Yoshitake, T., Inoue, O., Ibii, N., Kehr, J., Ishida, J., Nohta, H., & Yamaguchi, M. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00029-0 · Cited by 86
Regulation of Pituitary Vasopressin V1b Receptor mRNA during Stress in the Rat
Rabadan‐Diehl, C., Lolait, S. J., & Aguilera, G. (1995) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.1995.tb00734.x · Cited by 86
Review: Central non-glucocorticoid inhibitors of the hypothalamo-pituitary-adrenal axis
Jessop, D. (1999) · Journal of Endocrinology · doi:10.1677/joe.0.1600169 · Cited by 86
Elevated cerebrospinal fluid corticotropin-releasing ractor in Tourette's syndrome: Comparison to obsessive compulsive disorder and normal controls
Chappell, P. B., Leckman, J. F., Goodman, W. K., Bissette, G., Pauls, D. L., Anderson, G. M., Riddle, M. A., Scahill, L. D., McDougle, C. J., & Cohen, D. J. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00221-9 · Cited by 85
Colocalization of corticotropin-releasing factor and vasopressin in the paraventricular nucleus of the human hypothalamus
Mouri, T., Itoi, K., Takahashi, K., Suda, T., Murakami, O., Yoshinaga, K., Andoh, N., Ohtani, H., Masuda, T., & Sasano, N. (2008) · Neuroendocrinology · doi:10.1159/000126339 · Cited by 85
Acute and chronic effects of citalopram on postsynaptic 5‐hydroxytryptamine1A receptor‐mediated feedback: a microdialysis study in the amygdala
Bosker, F. J., Cremers, T. I. F. H., Jongsma, M. E., Westerink, B. H. C., Wikström, H., & den Boer, J. A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00194.x · Cited by 85
Enhanced Cortical Extracellular Levels of Cholecystokinin-Like Material in a Model of Anticipation of Social Defeat in the Rat
Becker, C., Thiébot, M.-H., Touitou, Y., Hamon, M., Cesselin, F., & Benoliel, J. J. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-01-00262.2001 · Cited by 84
Decreased Type 2 Corticotropin-Releasing Hormone Receptor mRNA Expression in the Ventromedial Hypothalamus during Repeated Immobilization Stress
Makino, S., Asaba, K., Nishiyama, M., & Hashimoto, K. (1999) · Neuroendocrinology · doi:10.1159/000054472 · Cited by 84
Effects of sequential removal of rats from a group cage, and of individual housing of rats, on substance P, cholecystokinin and somatostatin levels in the periaqueductal grey and limbic regions
Brodin, E., Rosén, A., Schött, E., & Brodin, K. (1994) · Neuropeptides · doi:10.1016/0143-4179(94)90079-5 · Cited by 84
Differential plasma catecholamine and neuropeptide Y responses to acute stress in rats
Żukowska-Grójec, Z., Konarska, M., & McCarty, R. C. (1988) · Life Sciences · doi:10.1016/0024-3205(88)90440-7 · Cited by 84
Untitled work
(1995) · PubMed · Cited by 84
The 5-HT1A receptor and its ligands: structure and function
Olivier, B., Soudijn, W., & van Wijngaarden, I. (1999) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8730-4_3 · Cited by 83
Role of 5-HT2A and 5-HT2C Receptor Subtypes in the Two Types of Fear Generated by the Elevated T-Maze
Mora, P. O., Netto, C. F., & Graeff, F. G. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00057-9 · Cited by 83
The Role of Ascending Neuronal Pathways in Stress‐Induced Release of Noradrenaline in the Hypothalamic Paraventricular Nucleus of Rats
Palkovits, M., Baffi, & Pacak (1999) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.1999.00365.x · Cited by 83
Daily Injections of Fluoxetine Induce Dose-Dependent Desensitization of Hypothalamic 5-HT1A Receptors: Reductions in Neuroendocrine Responses to 8-OH-DPAT and in Levels of Gz and Gi Proteins
Raap, D. K., Evans, S., García, F., Li, Q., Muma, N. A., Wolf, W. A., Battaglia, G., & de Kar, L. D. V. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37930-3 · Cited by 83
Stress-induced mesenteric vasoconstriction in rats is mediated by neuropeptide Y Y1 receptors
Żukowska-Grójec, Z., Dayao, E. K., Karwatowska‐Prokopczuk, E., Hauser, G. J., & Doods, H. N. (1996) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1996.270.2.h796 · Cited by 83
Deletion of CCK2Receptor in Mice Results in an Upregulation of the Endogenous Opioid System
Pommier, B., Beslot, F., Simon, A., Pophillat, M., Matsui, T., Daugé, V., Roques, B. P., & Noble, F. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-05-02005.2002 · Cited by 82
Neuroendocrinology in physiology and medicine
Kremer, J. A. M. (2000) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/s0301-2115(00)00249-9 · Cited by 81
Pituitary Adenylate Cyclase-Activating Polypeptide Stimulates Arginine Vasopressin Release in Conscious Rats
Murase, T., Kondo, K., Otake, K., & Oiso, Y. (2008) · Neuroendocrinology · doi:10.1159/000126475 · Cited by 80
Cerebrospinal fluid corticotropin-releasing hormone, vasopressin, and oxytocin concentrations in treated patients with major depression and controls
Pitts, A. F., Samuelson, S. D., Meller, W. H., Bissette, G., Nemeroff, C. B., & Kathol, R. G. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(95)00229-a · Cited by 79
Effect of the selective serotonin reuptake inhibitor fluvoxamine on CCK-4 induced panic attacks
van Megen, H. J. G. M., Westenberg, H. G. M., den Boer, J. A., Slaap, B. R., & Scheepmakers, A. (1997) · Psychopharmacology · doi:10.1007/s002130050201 · Cited by 79
Stress-Induced Changes in Cholecystokinin and Substance P Concentrations in Discrete Regions of the Rat Hypothalamus
Siegel, R. A., Düker, E.-M., Pahnke, U., & Wuttke, W. (2008) · Neuroendocrinology · doi:10.1159/000124799 · Cited by 79
Increased 5-Hydroxytryptamine-2 Receptor Binding in the Frontal Cortex of Depressed Patients Responding to Paroxetine Treatment: A Positron Emission Tomography Scan Study
Zanardi, R., Artigas, F., Moresco, R., Colombo, C., Messa, C., Gobbo, C. L., Smeraldi, E., & Fazio, F. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200102000-00010 · Cited by 79
An introduction to neuronal cholecystokinin
Beinfeld, M. C. (2001) · Peptides · doi:10.1016/s0196-9781(01)00442-9 · Cited by 78
Monoaminergic Regulation of Neuroendocrine Function and Its Modification by Cocaine
Levy, A. D., Baumann, M. H., & de Kar, L. D. V. (1994) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1994.1006 · Cited by 78
4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1 S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine Hydrochloride (SSR125543A): A Potent and Selective Corticotrophin-Releasing Factor1 Receptor Antagonist. I. Biochemical and Pharmacological Characterization
Gully, D., Geslin, M., Serva, L., Fontaine, E., Roger, P., Lair, C., Darre, V., MARCY, C. H., Rouby, P.-E., Simiand, J., et al. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.1.322 · Cited by 78
Differential Regulation of Neuropeptide Y mRNA Expression in the Arcuate Nucleus and Locus Coeruleus by Stress and Antidepressants
Makino, Baker, B. I., Smith, & Gold (2000) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2000.00451.x · Cited by 77
Monoamine metabolites, corticotropin releasing factor and somatostatin as CSF markers in depressed patients
Widerlöv, E., Bissette, G., & Nemeroff, C. B. (1988) · Journal of Affective Disorders · doi:10.1016/0165-0327(88)90051-1 · Cited by 77
Differential effects of naloxone on neuroendocrine responses to fear-related emotional stress
Onaka, T., & Yagi, K. (1990) · Experimental Brain Research · doi:10.1007/bf00230100 · Cited by 77
Vasoactive Intestinal Peptide Stimulates Adrenal Aldosterone and Corticosterone Secretion*
Cunningham, L. A., & Holzwarth, M. A. (1988) · Endocrinology · doi:10.1210/endo-122-5-2090 · Cited by 77
Effect of the anxiolytic drug buspirone on prolactin and corticosterone secretion in stressed and unstressed rats
Urban, J. H., de Kar, L. D. V., Lorens, S. A., & Bethea, C. L. (1986) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(86)90023-7 · Cited by 76
Central Actions of Corticotropin-Releasing Hormone (CRH) on Behavioral, Neuroendocrine, and Cardiovascular Regulation: Brain Corticoid Receptor Involvement
Korte, S. M., Bouws, G. A. H., & Bohus, B. (1993) · Hormones and Behavior · doi:10.1006/hbeh.1993.1013 · Cited by 76
Hormonal Responses to Insulin-Induced Hypoglycemia in Man*
Watabe, T., TANAKA, K., Kumagae, M., Itoh, S., Takeda, F., Morio, K., HASEGAWA, M., HORIUCHI, T., Miyabe, S., & Shimizu, N. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-65-6-1187 · Cited by 75
Species differences in the localization of ‘peripheral’ type cholecystokinin receptors in rodent brain
Hill, D. R., Shaw, T. M., & Woodruff, G. N. (1987) · Neuroscience Letters · doi:10.1016/0304-3940(87)90445-9 · Cited by 75
Plasma Neuropeptide Y Concentration Is Increased After Hemorrhage in Conscious Rats
Morris, M. J., Kapoor, V., & Chalmers, J. P. (1987) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-198705000-00006 · Cited by 75
Effects of corticotropin-releasing hormone on ovarian estrogen production in vitro
Calogero, A. E., Burrello, N., Negri‐Cesi, P., Papale, L., Palumbo, M. A., Cianci, A., Sanfilippo, S., & D’Agata, R. (1996) · Endocrinology · doi:10.1210/endo.137.10.8828472 · Cited by 75
Receptor signaling and structure: insights from serotonin-1 receptors
Albert, P. R., & Tiberi, M. (2001) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(01)00498-2 · Cited by 75
The cholecystokinin-B receptor antagonist CI-988 failed to affect CCK-4 induced symptoms in panic disorder patients
van Megen, H. J. G. M., Westenberg, H. G. M., den Boer, J. A., Slaap, B. R., Radhakishun, F. S., & Pande, A. C. (1997) · Psychopharmacology · doi:10.1007/s002130050186 · Cited by 75
Substance P Is Involved in Terminating the Hypothalamo-Pituitary-Adrenal Axis Response to Acute Stress Through Centrally Located Neurokinin-1 Receptors
Jessop, D. S., Renshaw, D. W., Larsen, P. J., Chowdrey, H. S., & Harbuz, M. S. (2000) · Stress · doi:10.3109/10253890009001125 · Cited by 74
Behavioral Effects of Central Administration of The Novel CRF Antagonist Astressin in Rats
Spina, M. G. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00108-6 · Cited by 74
Endocrine and receptor pharmacology of serotonergic anxiolytics, antipsychotics and antidepressants
Levy, A. D., & de Kar, L. D. V. (1992) · Life Sciences · doi:10.1016/0024-3205(92)90001-6 · Cited by 73
Substance P Inhibits the Release of Anterior Pituitary Adrenocorticotrophin via a Central Mechanism Involving Corticotrophin‐Releasing Factor‐Containing Neurons in the Hypothalamic Paraventricular Nucleus
Larsen, P. J., Jessop, D. S., Patel, H., Lightman, S. L., & Chowdrey, H. S. (1993) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.1993.tb00368.x · Cited by 73
Estrogen Augmentation of Gonadotropin-Stimulated Progestin Biosynthesis in Cultured Rat Granulosa Cells*
Welsh, T. H., Zhuang, L.-Z., & Hsueh, A. J. W. (1983) · Endocrinology · doi:10.1210/endo-112-6-1916 · Cited by 73
Neuropeptide Y in the adrenal gland: Characterisation, distribution and drug effects
de Quidt, M. E., & Emson, P. C. (1986) · Neuroscience · doi:10.1016/0306-4522(86)90313-1 · Cited by 73
Characterization of Three Corticotropin-Releasing Factor Receptors in Catfish: A Novel Third Receptor Is Predominantly Expressed in Pituitary and Urophysis
Arai, M. (2001) · Endocrinology · doi:10.1210/en.142.1.446 · Cited by 73
Intra-amygdala injection of the substance P (NK1 receptor) antagonist L-760735 inhibits neonatal vocalisations in guinea-pigs
Boyce, S., Smith, D., Carlson, E. J., Hewson, L., Rigby, M., O’Donnell, R., Harrison, T., & Rupniak, N. M. J. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00051-x · Cited by 72
STRESS-INDUCED SLEEP DEPRIVATION MODIFIES CORTICOTROPIN RELEASING FACTOR (CRF) LEVELS AND CRF BINDING IN RAT BRAIN AND PITUITARY
FADDA, P., & FRATTA, W. (1997) · Pharmacological Research · doi:10.1006/phrs.1997.0155 · Cited by 72
An Overview of SR121463, a Selective Non‐Peptide Vasopressin V2Receptor Antagonist
Gal, C. S. (2001) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2001.tb00065.x · Cited by 72
Behavioral Profile of CCK2 Receptor- deficient Mice
Daugé, V. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00291-3 · Cited by 71
Extracellular serotonin is decreased in the nucleus accumbens during withdrawal from cocaine self-administration
Parsons, L. H., KOOB, G. E., & Weiss, F. (1995) · Behavioural Brain Research · doi:10.1016/0166-4328(96)00101-5 · Cited by 71
Two novel mutations in the coding region for neurophysin-II associated with familial central diabetes insipidus
Nagasaki, H., Ito, M. A., Yuasa, H., Saito, H., Fukase, M., Hamada, K., Ishikawa, E., Katakami, H., & Oiso, Y. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.4.7714110 · Cited by 71
Substance P Stimulates Arginine Vasopressin and Inhibits Adrenocorticotropin Release in vivo in the Rat
Chowdrey, H. S., Jessop, D. S., & Lightman, S. L. (2008) · Neuroendocrinology · doi:10.1159/000125544 · Cited by 70
Corticotropin-releasing hormone receptor type 1-deficiency enhances hippocampal serotonergic neurotransmission: an in vivo microdialysis study in mutant mice
Peñalva, R. G., Flachskamm, C., Zimmermann, S., Wurst, W., Holsboer, F., Reul, J. M. H. M., & Linthorst, A. C. E. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00475-4 · Cited by 70
Axon terminals containing PACAP- and VIP-immunoreactivity form synapses with CRF-immunoreactive neurons in the dorsolateral division of the bed nucleus of the stria terminalis in the rat
Kozicz, T., Vigh, S., & Arimura, A. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00737-3 · Cited by 70
Baroreceptor influences on oxytocin and vasopressin secretion.
Morris, M. J., & Alexander, N. (1989) · Hypertension · doi:10.1161/01.hyp.13.2.110 · Cited by 70
The oCRH stimulation test before and after clinical recovery from depression
Amsterdam, J. D., Maislin, G., Winokur, A., Berwish, N. J., Kling, M. A., & Gold, P. W. (1988) · Journal of Affective Disorders · doi:10.1016/0165-0327(88)90037-7 · Cited by 70
An investigation of the mechanisms responsible for acute fluoxetine-induced anxiogenic-like effects in mice
Belzung, C., Guisquet, A. M. L., Barreau, S., & Calatayud, F. (2001) · Behavioural Pharmacology · doi:10.1097/00008877-200105000-00001 · Cited by 70
Comparison of neuroendocrine and behavioral effects of ipsapirone, a 5-HT1A agonist, in three stress paradigms: immobilization, forced swim and conditioned fear
Rittenhouse, P. A., Bakkum, E. A., O'Connor, P. A., Carnes, M. L., Bethea, C. L., & de Kar, L. D. V. (1992) · Brain Research · doi:10.1016/0006-8993(92)90946-7 · Cited by 68
Evidence That Gz-Proteins Couple to Hypothalamic 5-HT1AReceptorsIn Vivo
Serres, F., Li, Q., García, F., Raap, D. K., Battaglia, G., Muma, N. A., & de Kar, L. D. V. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-09-03095.2000 · Cited by 68
Isolation and Pharmacological Characterization of Two Functional Splice Variants of Corticotropin‐Releasing Factor Type 2 Receptor from Tupaia belangeri
Palchaudhuri, Hauger, Wille, Fuchs, & Dautzenberg (1999) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.1999.00348.x · Cited by 67
Pain and neurotransmitters
Otsuka, M., & Yanagisawa, M. (1990) · Cellular and Molecular Neurobiology · doi:10.1007/bf00711176 · Cited by 67
The panic-inducing properties of the cholecystokinin tetrapeptide CCK4 in patients with panic disorder
van Megen, H. J. G. M., Westenberg, H. G. M., den Boer, J. A., & Kahn, R. (1996) · European Neuropsychopharmacology · doi:10.1016/0924-977x(96)00018-1 · Cited by 66
Properties of rat anterior pituitary vasopressin receptors: relation to adenylate cyclase and the effect of corticotropin-releasing factor.
Gaillard, R.-C., Schoenenberg, P., Favrod-Coune, C. A., Muller, A. F., Marie, J., Bockaert, J., & Jard, S. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.9.2907 · Cited by 65
Prolactin in Autoimmune Diseases
Neidhart, M. (1998) · Experimental Biology and Medicine · doi:10.3181/00379727-217-44251 · Cited by 65
Corticotropin-releasing factor neurotransmission in locus coeruleus: A possible site of antidepressant action
Curtis, A. L., & Valentino, R. J. (1994) · Brain Research Bulletin · doi:10.1016/0361-9230(94)90172-4 · Cited by 64
Decreased Adrenal Sensitivity to ACTH in the Vasopressin-Deficient (Brattleboro) Rat
Wiley, M. K., Pearlmutter, A. F., & Miller, R. E. (2008) · Neuroendocrinology · doi:10.1159/000122269 · Cited by 64
Expression of Corticotropin-Releasing Hormone Type 1 Receptor in Paraventricular Nucleus after Acute Stress
Imaki, T., Katsumata, H., Miyata, M., Naruse, M., Imaki, J., & Minami, S. (2001) · Neuroendocrinology · doi:10.1159/000054646 · Cited by 64
Assessing the Comparative Effectiveness of Antidepressant Therapies
Parker, G. B., Roy, K., Wilhelm, K. A., & Mitchell, P. B. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n0209 · Cited by 64
Neuropeptide y- and alpha-adrenergic receptors in pig spleen: Localization, binding characteristics, cyclic amp effects and functional responses in control and denervated animals
Lundberg, J. M., Hemsén, A., Rudehill, A., Härfstrand, A., Larsson, O., Sollevi, A., Saria, A., Hökfelt, T. G. M., Fuxé, K., & Fredholm, B. B. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90359-4 · Cited by 63
ROLE OF THE DORSOMEDIAL HYPOTHALAMUS IN THE CARDIOVASCULAR RESPONSE TO STRESS
DiMicco, J. A., Stotz‐Potter, E. H., Monroe, A. J., & Morin, S. M. (1996) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1996.tb02592.x · Cited by 63
Ectopic expression of p27Kip1 in oligodendrocyte progenitor cells results in cell-cycle growth arrest
Tikoo, R., Osterhout, D. J., Casaccia‐Bonnefil, P., Seth, P. K., Koff, A., & Chao, M. V. (1998) · Journal of Neurobiology · doi:10.1002/(sici)1097-4695(19980905)36:3 · Cited by 62
Stress-induced changes of circulating neuropeptide Y in the rat: comparison with catecholamines
Castagné, V., Corder, R., Gaillard, R. C., & Mormède, P. (1987) · Regulatory Peptides · doi:10.1016/0167-0115(87)90074-7 · Cited by 62
Cholecystokinin and panic disorder: Past and future clinical research strategies
Bradwejn, D. K. J. (2001) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/clb.61.234.19.27 · Cited by 62
Effects of physiological manipulations on locus coeruleus neuronal activity in freely moving cats. III. Glucoregulatory challenge.
Morilak, D., Fornal, C., & Jacobs, B. (1987) · Brain Research · doi:10.1016/0006-8993(87)90537-3 · Cited by 62
Cholecystokinin and panic disorder: Past and future clinical research strategies
Bradwejn, J., & Koszycki, D. (2001) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/713783681 · Cited by 62
Effects of acute and chronic fluoxetine treatment on CRH-induced anxiety
To, C., Anheuer, Z. E., & Bagdy, G. (1999) · Neuroreport · doi:10.1097/00001756-199902250-00020 · Cited by 61

Flagged first, then by citations

13 of the 656 references couldn’t be matched to a known paper.

Research works printed but not linked: 8

Dahlstrom, 1965, Evidence for the existence of monoamine-containing neurons in the central nervous system IV, Acta Physiol. Scand., 64, 1
Deak, 1999, The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress, Endocrinology, 140, 79, 10.1210/en.140.1.79 · DOI · Paper page
Lorens, 1986, The serotonin antagonist LY53857, the 5-HT agonist 8-OH-DPAT, and intra-midbrain raphe, 5,7-dihidroxytryptamine lesions do not affect condiytioned fear induced increased in rennin secretion, Soc. Neurosci. Abstr., 12, 213
Parsons, 1996, Extracellular serotonin is decreased in the nucleus accumbens during withdrawal from cocaine self-administration, Behav. Brain Res., 73, 225, 10.1016/0166-4328(96)00101-5 · DOI
Santarelli, 2001, Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function, Proc. Natl. Acad. Sc. U. S. A., 98, 1912, 10.1073/pnas.041596398 · DOI
Van Megen, 1997, Effect of the selective serotonin reuptake inhibitor fluvoxamine on CCK-4 induced panic attacks, Psychopharmacology (Berl.), 129, 357, 10.1007/s002130050201 · DOI
Wank, 1995, Chosystokinin receptors, Am. J. Physiol., 269, G628
Zhang, 2001, Co-localization of 5-HT1A and 5-HT2A serotonin receptors on oxytocin cells in the hypothalamic paraventricular nucleus, Neurosci. Abstr., 17, 136

Sorted by citations

The expanded biology of serotonin
Berger, M., Gray, J. A., & Roth, B. L. (2009) · Annual Review of Medicine · doi:10.1146/annurev.med.60.042307.110802 · Cited by 2,100
The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress
Smith, S. M., & Vale, W. W. (2006) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2006.8.4/ssmith · Cited by 1,948
Hippocampal volume and depression: a meta-analysis of MRI studies
Videbech, P., & Ravnkilde, B. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.11.1957 · Cited by 1,590
The cortisol awakening response (CAR): Facts and future directions
Fries, E., Dettenborn, L., & Kirschbaum, C. (2009) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2008.03.014 · Cited by 1,188
The impact of stress on body function
Yaribeygi, H., Panahi, Y., Sahraei, H., Johnston, T. P., & Sahebkar, A. (2017) · EXCLI journal · doi:10.17179/excli2017-480 · Cited by 1,356

See all 914

Authors: Carrasco, G. A., & Van de Kar, L. D.
Affiliations: Loyola University Chicago (US)
ORCID: Carrasco, Gonzalo A
Venue: European Journal of Pharmacology
Publisher: Elsevier BV
Published: 2003-02
Volume: 463
Issue: 1-3
Pages: 235-272
ISSN: 0014-2999 (ISSN-L)
DOI: 10.1016/s0014-2999(03)01285-8
OpenAlex: W1971277989
Cited by: 914
References: 656
Citations by year: 2026: 7 · 2025: 11 · 2024: 24 · 2023: 27 · 2022: 29 · 2021: 37 · 2020: 32 · 2019: 30 · 2018: 36 · 2017: 27 · 2016: 36 · 2015: 34 · 2014: 43 · 2013: 64 · 2012: 49
FWCI: 21.36
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: European Journal of Pharmacology (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute on Drug Abuse (R01DA013669, DA 13669)
National Institute of Neurological Disorders and Stroke (NS34153)
Topics: Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
Keywords: stress response, neuroendocrine regulation, corticotropin-releasing factor, vasopressin, renin-angiotensin system, hypothalamic-pituitary-adrenal axis, catecholamines, serotonin, substance P, vasoactive intestinal peptide, neuropeptide Y, cholecystokinin, benzodiazepines, anxiolytics, antidepressants, anxiety disorders, glucocorticoids, ACTH, sympathetic nervous system, adrenal medulla
MeSH terms: Amygdala, Animals, Brain Chemistry, Endocrine System, Humans, Hypothalamus, Neurosecretory Systems, Stress, Physiological, Neurotransmitter Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Neuroendocrine pharmacology of stress

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks